55692-31-4Relevant articles and documents
PYRAZOLOTHIAZOLE COMPOUND AND MEDICINE
-
, (2017/07/31)
The invention provides a pyrazolothiazole compound of the formula [I], or a pharmaceutically acceptable salt thereof: The compound of the invention has JAK1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect and anti-proliferative effect, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis and vasculitis, bronchial asthma, chronic obstructive pulmonary disease and eosinophilic sinusitis, nasal polyp.
N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
-
, (2008/06/13)
Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as anti-arrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
N-(1-(ω-phenyl-alkyl)-piperidyl-4)-N-(α-pyridyl)-carboxylic acid amides and salts thereof
-
, (2008/06/13)
Compounds of the formula SPC1 Wherein R is straight or branched alkyl of 1 to 3 carbon atoms, alkoxy of 1 to 2 carbon atoms or phenyl, and n is an integer from 2 to 4, inclusive, And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as the salts are useful as non-narcotic analgesics.